INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook

Zacks Investment Research News Agency

2 days ago•Zacks Investment Research

Stocks Medium Importance Neutral

INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook

Indivior announces a merger with Supernus to form a CNS-focused biopharma company, tops Q2 earnings and revenue estimates and raises its 2026 outlook.

Related Symbols 1

I INDV INDV

Source: Zacks Investment Research

Visit Source

0 0 0

Comment

Comments

No comments yet

Be the first person to comment on this news item.

Category Stocks

Source Zacks Investment Research

Published 2 days ago

Likes 0

Comments 0

Shares 0

News ID #115

Status Published

This news may have been collected automatically from third-party sources. Please verify important information through the original source and other reliable sources before making any trading or investment decision. This content is provided for informational purposes only and does not constitute financial advice.

Keep comments relevant to the news topic and avoid offensive, promotional, spam, or misleading content.

INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook

Comments

User Menu